• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

培哚普利精氨酸盐与吲达帕胺固定复方制剂对动脉高血压患者的血管效应

[Vascular effects of perindopril arginine and indapamide fixed combination in patients with arterial hypertension].

作者信息

Protasov K V, Sinkevich D A, Reshina I V, Zhizhko N V, Logovikova S I, Golubeva L V

出版信息

Kardiologiia. 2012;52(9):8-14.

PMID:23098541
Abstract

The aim of the study was to investigate the dynamics of arterial stiffness and endothelial function parameters under the influence of perindopril arginine and indapamide fixed combination in arterial hypertension (AH) patients. 30 persons with 1-3 degree AH were included into the study. The treatment duration was 24 weeks. Central aortic blood pressure (BP), augmentation pressure and index (AIx), carotid-femoral and carotid-radial pulse wave velocity (PWV), brachial artery endothelium-dependent vasodilatation (EDVD), office and ambulatory BP as well as orthostatic BP falls were evaluated under the influence of selected therapy. 27 patients completed the study protocol. Results showed that aortic systolic BP was significantly reduced by 10.7 mmHg, augmentation pressure - by 3.6 mmHg and AIx - by 6.5%. Carotid-radial PWV decreased by 0.8 m/s. Carotid-femoral PWV did not change. We also revealed the EDVD increase by week 12. The EDVD growth was correlated with degree of aortic systolic BP reduction (r=-0.48, p=0.02). Office and ambulatory BP declined by 15.8/10.0 and 10.0/7.5 mmHg respectively. The target BP <140/90 mmHg was achieved in 20 (74.1%) persons. At the same time the orthostatic hypotension did not rise. Conclusion. We concluded that perindopril arginine/indapamide fixed combination improved vascular function in hypertensive patients by wave reflection reduction, peripheral arterial stiffness lowering and endothelial function improvement.

摘要

该研究的目的是调查在培哚普利精氨酸和吲达帕胺固定复方制剂影响下,动脉高血压(AH)患者动脉僵硬度和内皮功能参数的变化情况。30例1 - 3级AH患者纳入研究。治疗持续时间为24周。在所选治疗的影响下,评估中心主动脉血压(BP)、增强压和指数(AIx)、颈股和颈桡脉搏波速度(PWV)、肱动脉内皮依赖性血管舒张(EDVD)、诊室和动态血压以及直立性血压下降情况。27例患者完成了研究方案。结果显示,主动脉收缩压显著降低10.7 mmHg,增强压降低3.6 mmHg,AIx降低6.5%。颈桡PWV降低0.8 m/s。颈股PWV未改变。我们还发现第12周时EDVD增加。EDVD的增加与主动脉收缩压降低程度相关(r = -0.48,p = 0.02)。诊室和动态血压分别下降15.8/10.0和10.0/7.5 mmHg。20例(74.1%)患者达到目标血压<140/90 mmHg。同时,直立性低血压未升高。结论。我们得出结论,培哚普利精氨酸/吲达帕胺固定复方制剂通过减少波反射、降低外周动脉僵硬度和改善内皮功能,改善了高血压患者的血管功能。

相似文献

1
[Vascular effects of perindopril arginine and indapamide fixed combination in patients with arterial hypertension].培哚普利精氨酸盐与吲达帕胺固定复方制剂对动脉高血压患者的血管效应
Kardiologiia. 2012;52(9):8-14.
2
Amelioration of arterial properties with a perindopril-indapamide very-low-dose combination.培哚普利-吲达帕胺极低剂量联合用药改善动脉特性
J Hypertens Suppl. 2001 Nov;19(4):S15-20.
3
[Efficiency of triple antihypertensive therapy in patients with uncontrolled hypertension and depressive disorders].[三联抗高血压疗法对血压控制不佳且伴有抑郁障碍患者的疗效]
Ter Arkh. 2017;89(8):22-28. doi: 10.17116/terarkh201789822-28.
4
[Direct comparison of endothelial and metabolic effects of perindopril combination with indapamide retard or hydrochlorothiazide].培哚普利联合吲达帕胺缓释片或氢氯噻嗪对内皮及代谢影响的直接比较
Kardiologiia. 2014;54(11):25-9. doi: 10.18565/cardio.2014.11.25-29.
5
Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patient: a comparison with atenolol.低剂量培哚普利/吲达帕胺联合用药对高血压患者血压、动脉僵硬度和波反射的改善作用:与阿替洛尔的比较
Hypertension. 2001 Oct;38(4):922-6. doi: 10.1161/hy1001.095774.
6
[Optimization of Control of Blood Pressure, Metabolic Disorders and Target Organs Protection With Fixed Perindopril and Indapamide Combination in Treated Patients With Arterial Hypertension].[培哚普利吲达帕胺固定复方制剂对高血压治疗患者血压、代谢紊乱及靶器官保护的优化控制]
Kardiologiia. 2017 Feb;57(2):5-11.
7
Pulse wave velocity as endpoint in large-scale intervention trial. The Complior study. Scientific, Quality Control, Coordination and Investigation Committees of the Complior Study.脉搏波速度作为大规模干预试验的终点。Complior研究。Complior研究的科学、质量控制、协调和调查委员会
J Hypertens. 2001 Apr;19(4):813-8. doi: 10.1097/00004872-200104000-00019.
8
[Evaluation of the antihypertensive efficacy and tolerability of fixed very low-dose perindopril/indapamid combination in patients with mild to moderate hypertension. Results of a Czech and Slovak multicentric study].[培哚普利/吲达帕胺固定超低剂量复方制剂治疗轻至中度高血压患者的降压疗效及耐受性评估。捷克和斯洛伐克多中心研究结果]
Vnitr Lek. 2004 Jun;50(6):447-52.
9
Regression of left ventricular mass in hypertensive patients treated with perindopril/indapamide as a first-line combination: the REASON echocardiography study.培哚普利/吲达帕胺一线联合治疗高血压患者左心室质量的消退:REASON超声心动图研究
Am J Hypertens. 2004 Aug;17(8):660-7. doi: 10.1016/j.amjhyper.2004.03.681.
10
Evaluation of high dose of perindopril/indapamide fixed combination in reducing blood pressure and improving end-organ protection in hypertensive patients.评估高剂量培哚普利/吲达帕胺固定复方制剂在降低高血压患者血压及改善靶器官保护方面的作用。
Curr Med Res Opin. 2009 Sep;25(9):2271-80. doi: 10.1185/03007990903186787.

引用本文的文献

1
Vascular stiffening in pulmonary hypertension: cause or consequence? (2013 Grover Conference series).肺动脉高压中的血管硬化:原因还是结果?(2013年格罗弗会议系列)
Pulm Circ. 2014 Dec;4(4):560-80. doi: 10.1086/677370.
2
Which thiazide to choose as add-on therapy for hypertension?选择哪种噻嗪类药物作为高血压的附加治疗药物?
Integr Blood Press Control. 2014 Jul 30;7:35-47. doi: 10.2147/IBPC.S40248. eCollection 2014.